Home › Funds › BVF INC/IL › XFOR

BVF INC/IL position in XFOR

X4 PHARMACEUTICALS INC · Health Care

BVF INC/IL reported holding 2,233,742 shares of XFOR (X4 PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 0.27% of its reported portfolio and ranking #36 among its reported holdings. BVF INC/IL has disclosed XFOR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)2.23M sh
Reported value held$10.43M
Portfolio Weight0.27%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's XFOR position evolved

BVF INC/IL first disclosed a stake in XFOR in Q3 2025 at 2,233,742 shares (US$7.6M). The position peaked in Q2 2026 at 2,233,742 shares, worth US$10.4M. Across 4 filings, BVF INC/IL held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,233,742 shares valued at US$10.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.23M $7.64M New
Q4 2025 2.23M $8.93M Hold
Q1 2026 2.23M $9.23M Hold
Q2 2026 2.23M $10.43M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XFOR and 13F data

XFOR (X4 PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in XFOR — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$37.2M), PERCEPTIVE ADVISORS LLC (US$37.0M), Saturn V Capital Management LP (US$32.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XFOR

All XFOR fund holders →

FAQ

How long has BVF INC/IL held XFOR?

BVF INC/IL has disclosed XFOR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is BVF INC/IL's current position in XFOR?

As of Q2 2026, BVF INC/IL holds 2.23M shares of XFOR (X4 PHARMACEUTICALS INC), valued at $10.43M, representing 0.27% of its reported portfolio and ranking #36.

Has BVF INC/IL been buying or selling XFOR?

In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in XFOR. The position peaked in Q2 2026 at 2.23M shares.

Which other funds hold XFOR?

Other major institutional holders of XFOR include Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.